These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6096859)

  • 1. Mouse c-mos oncogene activation is prevented by upstream sequences.
    Wood TG; McGeady ML; Baroudy BM; Blair DG; Vande Woude GF
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7817-21. PubMed ID: 6096859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequences upstream from the mouse c-mos oncogene may function as a transcription termination signal.
    McGeady ML; Wood TG; Maizel JV; Vande Woude GF
    DNA; 1986 Aug; 5(4):289-98. PubMed ID: 3017657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequences in the long terminal repeats of the Moloney murine sarcoma virus-124 genome which control transforming gene function.
    Narayanan R; Srinivasan A; Aaronson SA
    Virology; 1984 Aug; 137(1):32-40. PubMed ID: 6089418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region.
    Ohuchi T; Kurita Y; Sasai H; Miyoshi J; Nomura T; Toyoshima K
    Oncogene; 1992 Feb; 7(2):331-8. PubMed ID: 1532243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of c-mos oncogene by integration of an endogenous long terminal repeat element during transfection of genomic DNA from mouse skin tumor cells.
    Wang S; Nishigori C; Miyakoshi J; Tsukada T; Shung B; Yagi T; Takebe H
    Oncogene; 1993 Apr; 8(4):1009-16. PubMed ID: 8455928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functions of the mos oncogene family and associated gene products.
    Bold RJ; Hannink M; Donoghue DJ
    Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of activation of the mouse c-mos oncogene by the LTR of an intracisternal A-particle gene.
    Horowitz M; Luria S; Rechavi G; Givol D
    EMBO J; 1984 Dec; 3(12):2937-41. PubMed ID: 6098457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long terminal repeat enhancement of v-mos transforming activity: identification of essential regions.
    Wood TG; McGeady ML; Blair DG; Vande Woude GF
    J Virol; 1983 Jun; 46(3):726-36. PubMed ID: 6190012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
    Sergiescu D; Gerfaux J; Joret AM; Chany C
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel transposon-like repeat interrupted by an LTR element occurs in a cluster of B1 repeats in the mouse c-mos locus.
    Propst F; Vande Woude GF
    Nucleic Acids Res; 1984 Nov; 12(22):8381-92. PubMed ID: 6095198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of c-mos proto-oncogene transcripts in mouse tissues.
    Propst F; Vande Woude GF
    Nature; 1985 Jun 6-12; 315(6019):516-8. PubMed ID: 4000280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecularly cloned c-mos(rat) is biologically active.
    van der Hoorn FA; Hulsebos E; Berns AJ; Bloemers HP
    EMBO J; 1982; 1(11):1313-7. PubMed ID: 6327263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chicken homolog of the mos proto-oncogene.
    Schmidt M; Oskarsson MK; Dunn JK; Blair DG; Hughes S; Propst F; Vande Woude GF
    Mol Cell Biol; 1988 Feb; 8(2):923-9. PubMed ID: 2832744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus.
    Watson R; Oskarsson M; Vande Woude GF
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4078-82. PubMed ID: 6287464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis underlying phenotypic revertants of Moloney murine sarcoma virus MuSVts110.
    Cizdziel PE; Nash MA; Blair DG; Murphy EC
    J Virol; 1986 Jan; 57(1):310-7. PubMed ID: 3001354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis.
    Blair DG; Oskarsson M; Wood TG; McClements WL; Fischinger PJ; Vande Woude GG
    Science; 1981 May; 212(4497):941-3. PubMed ID: 7233190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus.
    Stocking C; Kollek R; Bergholz U; Ostertag W
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5746-50. PubMed ID: 2994046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome.
    Canaani E; Dreazen O; Klar A; Rechavi G; Ram D; Cohen JB; Givol D
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7118-22. PubMed ID: 6316344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
    Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C
    Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.
    Jaggi R; Salmons B; Muellener D; Groner B
    EMBO J; 1986 Oct; 5(10):2609-16. PubMed ID: 3023051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.